precaution-covid-19-corona-virus
, ,

Vysnova CoVID-19 Guidance to Staff

As the situation regarding the novel coronavirus (COVID-19) continues to evolve, the Vysnova Management team wants to make sure that everyone knows that the health and safety of our Employees and Consultants is our top priority. Please see…
Global Health Security Agenda: CDC Drives 5 Years of Progress; Threats Remain
,

Global Health Security Agenda: CDC Drives 5 Years of Progress; Threats Remain

In today’s globalized world, a disease threat anywhere is a disease threat everywhere.    The Global Health Security Agenda (GHSA) is an international effort to strengthen the world’s ability to prevent, detect, and respond…
world-birth-defects-day-vysnova
, , ,

World Birth Defects Day

World Birth Defects Day Today is World Birth Defects Day and we would like to take a moment to highlight the work of one of our partners, the Centers for Disease Control and Prevention (CDC).  The VEZ ZEN program is the result of a collaboration…
vysnova-mentioned-cdc-article
,

Vysnova Partners Acknowledged In Supporting Zika Global Health Program

  Vysnova Partners Acknowledged In Supporting Zika Global Health Program News update from Vysnova VEZ & ZEN program Vysnova Partners was recently acknowledged in supporting the global health program on Zika research in Colombia by the…
top-public-research-management-company
,

Project Spotlight: Southeast Asia Biosurveillance and Epidemiology Research

The Problem: The current global disease control strategy is focused almost entirely on responding to pandemics after they have emerged, leaving the global community vulnerable to rising human health threats. The emergence of Ebola and the…
Zika Research in Infants and Pregnant Women in Colombia
,

Project Spotlight: Zika Research in Infants and Pregnant Women in Colombia

The Problem: Zika Virus (ZIKV) was declared a global health threat in 2016.  Although most of the cases can be attributed to infected bites of Aedes aegypti and Aedes albopictus mosquitoes, a proportion of new Zika infections are due to…
Vysnova Partners Inc. Awarded TO 0738 Under NAMRU-2 SABER II IDIQ Contract
, , ,

Vysnova Partners Inc. Awarded TO 0738 Under NAMRU-2 SABER II IDIQ Contract

Vysnova Partners Inc. Awarded TO 0738 Under NAMRU-2 SABER II IDIQ Contract September 30, 2018:  Vysnova Partners Inc. (Vysnova) has been awarded Task Order N6264518F0738 (TO 0738) under the Navy Medical Unit 2 (NAMRU 2) Southeast Asia Biosurveillance…
Vysnova Supports Enhancing Civilian-Military Cooperation
,

Vysnova Supports Enhancing Civilian-Military Cooperation to Accelerate Malaria Elimination in Southeast Asia

The Heads of State from the Association of Southeast Asian Nations (ASEAN) member nations stated their commitment to an “Asia Pacific free of Malaria by 2030” at the 9th East Asia Summit – which was sponsored by Vysnova Partners. This…